Abstract

Proteomic signatures found in serum EV of CCA, PSC, and HCC patients show potential usefulness as diagnostic tools. (Hepatology 2017;66:1125-1143).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis
Leslie Morton ... Thiago M De Assuncao
Laboratory Investigation | VOL. 97
Leslie Morton, et. al.Leslie Morton ... Thiago M De Assuncao
01 Nov 2017
Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.
Steven P O’Hara ... Christy E Trussoni
Liver international : official journal of the International Association for the Study of the Liver | VOL. 40
Steven P O’Hara, et. al.Steven P O’Hara ... Christy E Trussoni
07 Jul 2020
Primary sclerosing cholangitis-A long night's journey into day.
Roger W Chapman
Clinical liver disease | VOL. 20
Roger W ChapmanRoger W Chapman
01 Nov 2022
Diagnosis and management of primary sclerosing cholangitis
Kirsten Muri Boberg ... Roger Chapman
Hepatology | VOL. 51
Kirsten Muri Boberg, et. al.Kirsten Muri Boberg ... Roger Chapman
09 Sep 2009
View more papers

More From: Hepatology (Baltimore, Md.)

Paper Title
Journal
Date
Author
Platelet-mediated circulating tumor cell evasion from natural killer cell killing via immune checkpoint CD155-TIGIT.
Yunfan Sun ... Wei Guo
Hepatology (Baltimore, Md.) | VOL. -
Yunfan Sun, et. al.Yunfan Sun ... Wei Guo
23 May 2024
Low MBOAT7 expression, a genetic risk for MASH, promotes a pro-fibrotic pathway involving hepatocyte TAZ upregulation.
Mary P Moore ... Ira Tabas
Hepatology (Baltimore, Md.) | VOL. -
Mary P Moore, et. al.Mary P Moore ... Ira Tabas
22 May 2024
Cathepsins prime hepatitis E virus for cell entry.
Zongdi Feng
Hepatology (Baltimore, Md.) | VOL. -
Zongdi FengZongdi Feng
22 May 2024
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study.
Stanislas Pol ... Joseph S Doyle
Hepatology (Baltimore, Md.) | VOL. -
Stanislas Pol, et. al.Stanislas Pol ... Joseph S Doyle
20 May 2024
View more papers